Skip to main content
Cachet Pharmaceutical Co., Ltd. logo

Cachet Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 002462 ISIN · CNE100000SN0 LEI · 300300CBONJS7HUOCX64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,441 across all filing types
Latest filing 2019-04-24 Interim / Quarterly Rep…
Country CN China
Listing Shenzhen Stock Exchange 002462

About Cachet Pharmaceutical Co., Ltd.

https://www.cachet.com.cn

Cachet Pharmaceutical Co., Ltd. specializes in the distribution and retail of pharmaceutical products and medical devices. The company operates an extensive wholesale network and a chain of retail pharmacies, providing comprehensive supply chain solutions to healthcare institutions and end-consumers. Its core operations include the procurement, storage, and logistics of western medicines, traditional Chinese medicines, and high-value medical consumables. Cachet Pharmaceutical emphasizes modern logistics management and professional pharmaceutical services, leveraging a robust distribution infrastructure to ensure the efficient delivery of healthcare products. The company also focuses on hospital supply chain integration and community-based retail services to enhance healthcare accessibility.

Recent filings

Filing Released Lang Actions
2019年第一季度报告全文（更新后）
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2019 First Quarter Report" of 嘉事堂药业股份有限公司, indicating it is a quarterly financial report. It contains detailed financial data including consolidated and parent company balance sheets, profit and loss statements, cash flow information, and management commentary on financial performance and significant events during the quarter. The length of the document (15,000 characters) and the presence of comprehensive financial statements confirm it is a full interim report rather than a brief announcement or certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q1 2019
2019-04-24 Chinese
关于2019年一季度报告的补充更正公告
Interim / Quarterly Report Classification · 95% confidence The document is a public announcement by 嘉事堂药业股份有限公司 regarding a supplementary correction to their previously published 2019 first quarter report. It references the implementation of new financial instrument accounting standards effective from January 1, 2019, and details adjustments to financial statement line items such as assets and liabilities. The document includes detailed financial tables showing restated figures and explanations for the adjustments. It explicitly states that the correction is to the 2019 first quarter report (an interim/quarterly report) and that the original report was published on April 24, 2019. The document is 5843 characters long, which is sufficient to contain substantive financial data and analysis, not merely an announcement of a report or a certification. Therefore, this document is a corrected or supplementary interim/quarterly financial report, fitting the definition of an Interim / Quarterly Report (IR). Q1 2019
2019-04-24 Chinese
关于高级管理人员变动的公告
Board/Management Information Classification · 100% confidence The document is an announcement from 嘉事堂药业股份有限公司 regarding changes in senior management personnel, including appointments of the company president and vice presidents. It includes detailed biographies of the newly appointed executives and confirms compliance with relevant regulations. There is no financial data, earnings information, or report publication mentioned. The content clearly fits the category of announcing changes in the company's board or senior management.
2019-04-23 Chinese
2019年第一季度报告全文（已取消）
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2019 年第一季度报告全文" which translates to "2019 First Quarter Report Full Text." It contains detailed financial data including consolidated and parent company balance sheets, profit and loss statements, cash flow information, and notes on financial performance for the first quarter of 2019. The presence of comprehensive financial statements and analysis for a quarterly period clearly indicates this is a quarterly financial report. The document length is substantial (15,000 characters), and it contains actual financial data rather than just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2019
2019-04-23 Chinese
第六届监事会第一次会议决议的公告
Regulatory Filings Classification · 95% confidence The document is an announcement of the resolutions passed at the first meeting of the sixth Supervisory Board of the company. It includes the election of the Supervisory Board chairman and the review and approval of the company's 2019 first quarter report. The document does not contain the full quarterly report itself but references the report and states where it can be found. The document is relatively short (1965 characters) and serves as a formal announcement of meeting decisions and approvals rather than the report itself. Therefore, it fits best into the category of Regulatory Filings (RNS), as it is a regulatory announcement about supervisory board decisions and report approval, not the full interim report or financial statements.
2019-04-23 Chinese
独立董事关于公司第六届董事会第一次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion from the independent directors regarding the appointment of senior management and the board secretary at the company's sixth board meeting. It references compliance with company law, stock exchange rules, and internal governance documents. The content focuses on board and management personnel changes rather than financial results, audit, or other report types. The document length is short (1213 characters) and contains detailed opinions on management appointments, which aligns with announcements about board or management changes. Therefore, the document fits best under Board/Management Information (MANG).
2019-04-23 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.